The Autorité de la concurrence acknowledges the recent judgment by the Court of Justice of the European Union regarding the Illumina / Grail case, which annulled the General Court ruling and the European Commission's decision to review the acquisition of Grail by Illumina. Several EU Member States supported France's referral request in this matter.

For years, the Autorité de la concurrence has been actively using available tools to address acquisitions that threaten competition in areas like digital innovation, healthcare, and biotech. Recognizing the importance of maintaining innovation dynamics in the economy, the Autorité de la concurrence is committed to preventing mergers that could strengthen market power in innovative sectors.

The Autorité de la concurrence will analyze the EU Court of Justice's judgment carefully to determine the necessary measures to prevent anti-competitive mergers, even those not subject to prior notification. It plans to utilize existing competition law provisions at both EU and national levels to safeguard competition in France.

In addition to preserving legal certainty for businesses, the Autorité de la concurrence is considering enhancing its merger control tools under national law to address potentially problematic mergers that fall below current notification thresholds in France.